spacer
spacer

PDBsum entry 4mxy

Go to PDB code: 
protein ligands Protein-protein interface(s) links
Transferase/transferase inhibitor PDB id
4mxy

 

 

 

 

Loading ...

 
JSmol PyMol  
Contents
Protein chains
266 a.a.
Ligands
DB8 ×2
Waters ×66
PDB id:
4mxy
Name: Transferase/transferase inhibitor
Title: Src m314l t338m double mutant bound to kinase inhibitor bosutinib
Structure: Proto-oncogene tyrosine-protein kinase src. Chain: a, b. Fragment: kinase domain, unp residues 254-536. Synonym: proto-oncogenE C-src, pp60c-src, p60-src. Engineered: yes. Mutation: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Gene: src, src1. Expressed in: escherichia coli. Expression_system_taxid: 562
Resolution:
2.58Å     R-factor:   0.211     R-free:   0.266
Authors: N.M.Levinson,S.G.Boxer
Key ref: N.M.Levinson and S.G.Boxer (2014). A conserved water-mediated hydrogen bond network defines bosutinib's kinase selectivity. Nat Chem Biol, 10, 127-132. PubMed id: 24292070 DOI: 10.1038/nchembio.1404
Date:
26-Sep-13     Release date:   25-Dec-13    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P12931  (SRC_HUMAN) -  Proto-oncogene tyrosine-protein kinase Src from Homo sapiens
Seq:
Struc:
 
Seq:
Struc:
536 a.a.
266 a.a.*
Key:    PfamA domain  Secondary structure  CATH domain
* PDB and UniProt seqs differ at 2 residue positions (black crosses)

 Enzyme reactions 
   Enzyme class: E.C.2.7.10.2  - non-specific protein-tyrosine kinase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
L-tyrosyl-[protein]
+ ATP
= O-phospho-L-tyrosyl-[protein]
+ ADP
+ H(+)
Molecule diagrams generated from .mol files obtained from the KEGG ftp site

 

 
    Added reference    
 
 
DOI no: 10.1038/nchembio.1404 Nat Chem Biol 10:127-132 (2014)
PubMed id: 24292070  
 
 
A conserved water-mediated hydrogen bond network defines bosutinib's kinase selectivity.
N.M.Levinson, S.G.Boxer.
 
  ABSTRACT  
 
Kinase inhibitors are important cancer drugs, but they tend to display limited target specificity, and their target profiles are often challenging to rationalize in terms of molecular mechanism. Here we report that the clinical kinase inhibitor bosutinib recognizes its kinase targets by engaging a pair of conserved structured water molecules in the active site and that many other kinase inhibitors share a similar recognition mechanism. Using the nitrile group of bosutinib as an infrared probe, we show that the gatekeeper residue and one other position in the ATP-binding site control access of the drug to the structured water molecules and that the amino acids found at these positions account for the kinome-wide target spectrum of the drug. Our work highlights the importance of structured water molecules for inhibitor recognition, reveals a new role for the kinase gatekeeper and showcases an effective approach for elucidating the molecular origins of selectivity patterns.
 

 

spacer

spacer